161 research outputs found
Chemical Speciation of Thorium in Marine Biogenic Particulate Matter
Concentrations of particulate thorium in seawater were determined together with the strong organic ligand (SOL) and uranium in particulate matter (PM). The concentrations of particulate Th in surface waters of the western North Pacific and the Sea of Japan ranged from 0.05 to 1.5 pM (1 x 10−12 M), and showed relatively large temporal and spatial variations. In order to chemically characterize the particulate Th in seawater, the relationship between particulate Th and SOL concentrations in surface PM was examined. The result reveals that particulate Th in surface PM was well correlated with the SOL concentration in PM. The concentrations of particulate Th in surface water were linearly related to those of particulate U. Mass balance analysis suggests that the dominant chemical form of Th(IV), as well as of U, in surface PM is a surface complex with the SOL in PM. Our findings suggest that the SOL in PM is a nonmetal-specific chelator originating from the cell surface of microorganisms
Improvement of 137Cs analysis in small volume seawater samples using the Ogoya underground facility
137Cs in seawater is one of the most powerful tracers of water motion. Large volumes of samples have been required for determination of 137Cs in seawater. This paper describes improvement of separation and purification processes of 137Cs in seawater, which includes purification of 137Cs using hexachloroplatinic acid in addition to ammonium phosphomolybdate (AMP) precipitation. As a result, we succeeded the 137Cs determination in seawater with a smaller sample volume of 10 liter by using ultra-low background gamma-spectrometry in the Ogoya underground facility. 137Cs detection limit was about 0.1 mBq (counting time: 106 s). This method is applied to determine 137Cs in small samples of the South Pacific deep waters. © 2008 Springer Science+Business Media, LLC
Measuring Vision With Temporally Modulated Stripes in Infants and Children with ROP
Purpose. To determine differences in preferential looking (PL) acuities using stationary and temporally modulated stripe patterns in patients with various stages of retinopathy of prematurity (ROP). Methods. We measured the PL acuities of 134 patients (ages 4 mo to 13 yr) with various stages of ROP. Patients were divided into six subgroups according to PL vision measured with stationary stripes: (1) equal to or better than 20/200 (n = 24); (2) worse than 20/200 to 20/400 (n = 10); (3) worse than 20/400 to 20/800 (n = 15); (4) worse than 20/800 to 20/1600 (n = 13); (5) worse than 20/1600 to 20/6400 (n = 26); and (6) worse than 20/6400 (n = 46; no stationary vision). Results. In the group with PL acuity equal to or better than 20/200, no difference in vision was apparent between the two methods. In patients with acuities worse than 20/200 to 20/400, the temporally modulated PL acuities were 0.23 octave better than the PL acuities measured with the stationary stripes. The difference increased to 0.86 and 1.12 octaves in the groups with visual acuities worse than 20/400 to 20/800 and worse than 20/800 to 20/1600, respectively. The difference in the group with PL acuities worse than 20/1600 to 20/6400 was 1.69 octaves. The 46 patients with no stationary vision detected only the temporally modulated stripes. Conclusions. The results suggest that the PL acuity difference between the temporally modulated and stationary stripes increases with visual impairment. Measuring PL acuity with temporally modulated stripes is an important addition to the evaluation of severely visually impaired subjects. Invest Ophthalmol Vis Sci. 1993;34:496-502. A he preferential looking (PL) test has been useful in clinical settings to evaluate vision in infants and young children. However, some patients with severe visual impairment cannot discriminate the lowest spatial freFrom. th
Angioscopic Evaluation of Stabilizing Effects of Bezafibrate on Coronary Plaques in Patients With Coronary Artery Disease
Background Since long-term administrations of anti-hyperlipidemic
agents result in reduction in % stenosis or increase in
minimum lumen diameter (MLD) of stenotic coronary
segments, it is generally believed that anti-hyperlipidemic agents
stabilize vulnerable coronary plaques. However, recent pathologic
and angioscopic studies revealed that vulnerability of coronary
plaques is not related to severity of stenosis and the rims rather
than top of the plaques disrupt, and therefore, angiography is not
adequate for evaluation of vulnerability
Single nucleotide variations in CLCN6 identified in patients with benign partial epilepsies in infancy and/or febrile seizures
Nucleotide alterations in the gene encoding proline-rich transmembrane protein 2 (PRRT2) have been identified in most patients with benign partial epilepsies in infancy (BPEI)/benign familial infantile epilepsy (BFIE). However, not all patients harbor these PRRT2 mutations, indicating the involvement of genes other than PRRT2. In this study, we performed whole exome sequencing analysis for a large family affected with PRRT2-unrelated BPEI. We identified a non-synonymous single nucleotide variation (SNV) in the voltage-sensitive chloride channel 6 gene (CLCN6). A cohort study of 48 BPEI patients without PRRT2 mutations revealed a different CLCN6 SNV in a patient, his sibling and his father who had a history of febrile seizures (FS) but not BPEI. Another study of 48 patients with FS identified an additional SNV in CLCN6. Chloride channels (CLCs) are involved in a multitude of physiologic processes and some members of the CLC family have been linked to inherited diseases. However, a phenotypic correlation has not been confirmed for CLCN6. Although we could not detect significant biological effects linked to the identified CLCN6 SNVs, further studies should investigate potential CLCN6 variants that may underlie the genetic susceptibility to convulsive disorders.Toshiyuki Yamamoto, Keiko Shimojima, Noriko Sangu, Yuta Komoike, Atsushi Ishii, Shinpei Abe, Shintaro Yamashita, Katsumi Imai, Tetsuo Kubota, Tatsuya Fukasawa, Tohru Okanishi, Hideo Enoki, Takuya Tanabe, Akira Saito, Toru Furukawa, Toshiaki Shimizu, Carol J. Milligan, Steven Petrou, Sarah E. Heron, Leanne M. Dibbens, Shinichi Hirose, Akihisa Okumur
Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54–56 Gy given in 9–7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size
- …